Stay updated with breaking news from Genomatix Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Clinical Oncology Next Generation Sequencing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The...
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Clinical Oncology Next Generation Sequencing Global Market Report 2022" report has been added to...
The Clinical Oncology Next Generation Sequencing Market report helps to build the strategic plan by finding an intricate match between strategy and operation, strategic positioning of new product and services which depends on doing many things well, it showcases the understanding of the management cycle that links the strategy and operation and tells what tools to apply at each stage of the cycle, along with component of a management system which includes the integrated set of process and tools that a company uses to develop its strategy, translate it into operational action, and monitor and...
Share this article Share this article ResearchAndMarkets.com's offering. The global clinical oncology next generation sequencing market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The growth is mainly due to the companies resuming their ope...